Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
EMA guidance · 2026-07-10Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026
PRAC meeting highlights include new safety information for desogestrel- and etonogestrel-containing contraceptives and for Litfulo (ruxoliti…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata [Phase 3]
This document reports an ongoing Phase 3 clinical trial of baricitinib (LY3009104) in children aged 6 to under 18 with alopecia areata, whic…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata [Phase 3]
A Phase 3 clinical trial is evaluating the safety and effectiveness of Upadacitinib tablets in adults and adolescents with severe alopecia a…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) [Phase 2]
A Phase 2 clinical trial evaluating LY4005130 in adults with severe alopecia areata is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata [Phase 2]
This entry describes a Phase 2 trial to evaluate the safety and efficacy of oral NXC-736 in adults with moderate to severe alopecia areata; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA) [Phase 2]
A Phase 2b clinical trial (Rezolve AA) is evaluating Rezpegaldesleukin (Rezpeg) for treating severe to very severe alopecia areata in adult …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata [Phase 3]
Pfizer is conducting a Phase 3 trial of ritlecitinib in children aged 6 to 12 with severe alopecia areata, and the study is currently recrui…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata
A clinical trial is investigating whether serum VEGF-A and VCAM-1 levels associate with nailfold capillary alterations in patients with Alop…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: TREg Activation in the Treatment of the PELADE (Alopecia Areata) [Phase 3]
The document notes the completion of a Phase 3 trial evaluating TREg activation for alopecia areata.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Improving Disease Severity [NA]
A Wake Forest University Health Sciences-sponsored clinical trial update reports a completed study aimed at improving disease severity in ps…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Topical Methotrexate vs Minoxidil for Localized Alopecia Areata [Phase 4]
Phase 4 trial comparing topical methotrexate to minoxidil for localized alopecia areata; currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Association of TLR7 Gene rs3853839 Polymorphism With Disease Severity in Alopecia Areata: A Case-Control Study
A completed case-control study examines whether the TLR7 rs3853839 polymorphism is associated with disease severity in alopecia areata.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata
A completed clinical trial conducted at Benha University examined whether the NR3C1 rs41423247 (BclI) polymorphism influences disease severi…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata [Phase 4]
This update describes a Phase 4 clinical trial comparing topical calcipotriol to intralesional steroids for alopecia areata. The study statu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata [Phase 1, Phase 2]
This clinical trial update notes that ALD-102 Solution is being studied in Phase 1/2 to evaluate safety, tolerability, pharmacokinetics, and…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Litfulo Capsules Special Investigation
Pfizer reports that a special investigation trial of Litfulo capsules in Alopecia Areata is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Dupilumab in the Treatment of Pediatric Alopecia Areata [Phase 2]
A Phase 2 clinical trial evaluating dupilumab for pediatric alopecia areata is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Pfizer is reporting a clinical trial update on ritlecitinib for Alopecia Areata, describing the characterization and clinical outcomes obser…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
A real-world, global study to assess disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
Pfizer-sponsored real-world study evaluating the use and effectiveness of ritlecitinib for severe alopecia areata in the United States; recr…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA) [Phase 4]
A Phase 4 clinical trial comparing tofacitinib versus methotrexate for severe alopecia areata is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases [NA]
A completed clinical trial update reporting an in vitro study of interleukin-2 muteins on regulatory T cells in patients with autoimmune, al…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, pharmacokinetics, and efficacy of IMG-007 in adults with alopecia areata has completed and…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Clinical trial registry entry for CorEvitas' International Adolescent Alopecia Areata Drug Safety and Effectiveness Registry, currently recr…